Teladoc Health: Expected Slowdown

 

  • Teladoc Health reports strong Q1 financials.
  • The telehealth platform provider provided company metrics showing the business peaked for this cycle.
  • The stock trades at an expensive 11x forward revenues, considering the tough comps for the year.
  • Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio. Learn More »
Despite Teladoc Health (TDOC) forecasting that business will still top the COVID-19 boost in most metrics, the stock is falling by nearly 10%. The telehealth provider is forecasting a major slowdown in new members and total visit growth for the year as the company faces tough comps. My investment thesis remains bearish on the stock for now.

Read the full article on Seeking Alpha. 

Update - May 6

The stock for Teladoc Health continues to be line with more and more competition. First, Amwell (AMWL) apparently took Pepsi as a customer and now Walmart (WMT) is buying a competitor. 

  • Teladoc Health (NYSE:TDOC) fell 2.7% in after hours trading after Walmart (NYSE:WMT)  announced that it agreed to buy telehealth provider MeMD.
  • Walmart said the purchase will allow Walmart Health to provide access to virtual care across the nation including urgent, behavioral, and primary care, according to a statement. The acquisition is expected to close in the coming months.
Investors should avoid Teladoc Health until all of this shakes out and competition is no longer interested in joining the telehealth race. 

Finviz Chart


Disclosure: No position mentioned. Please review the disclaimer page for more details. 


Popular posts from this blog

Aurora Cannabis: Deal Or No Deal

Skillz: Back To Earth

Velodyne Lidar: Painful Progress